Simply Better Brands Past Earnings Performance
Past criteria checks 0/6
Simply Better Brands's earnings have been declining at an average annual rate of -51.7%, while the Pharmaceuticals industry saw earnings growing at 43.4% annually. Revenues have been growing at an average rate of 39.2% per year.
Key information
-51.7%
Earnings growth rate
-93.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 39.2% |
| Return on equity | -357.4% |
| Net Margin | -30.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investor Optimism Abounds Simply Better Brands Corp. (CVE:SBBC) But Growth Is Lacking
Nov 20
Simply Better Brands Corp. (CVE:SBBC) Soars 26% But It's A Story Of Risk Vs Reward
Jul 14Market Might Still Lack Some Conviction On Simply Better Brands Corp. (CVE:SBBC) Even After 43% Share Price Boost
May 21Is Simply Better Brands (CVE:SBBC) Using Debt Sensibly?
Mar 29Simply Better Brands Corp. (CVE:SBBC) Screens Well But There Might Be A Catch
Feb 02Further Upside For Simply Better Brands Corp. (CVE:SBBC) Shares Could Introduce Price Risks After 27% Bounce
Apr 17Calculating The Intrinsic Value Of PureK Holdings Corp. (CVE:PKAN)
Mar 10Revenue & Expenses Breakdown
How Simply Better Brands makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 73 | -22 | 45 | 0 |
| 30 Jun 24 | 81 | -26 | 53 | 0 |
| 31 Mar 24 | 82 | -22 | 52 | 0 |
| 31 Dec 23 | 80 | -24 | 54 | 0 |
| 30 Sep 23 | 63 | -11 | 37 | 0 |
| 30 Jun 23 | 57 | -12 | 34 | 0 |
| 31 Mar 23 | 65 | -12 | 44 | 0 |
| 31 Dec 22 | 65 | -12 | 49 | 0 |
| 30 Sep 22 | 49 | -11 | 39 | 0 |
| 30 Jun 22 | 39 | -16 | 37 | 0 |
| 31 Mar 22 | 25 | -15 | 27 | 0 |
| 31 Dec 21 | 16 | -13 | 18 | 0 |
| 30 Sep 21 | 12 | -11 | 14 | 0 |
| 30 Jun 21 | 12 | -5 | 8 | 0 |
| 31 Mar 21 | 12 | -3 | 7 | 0 |
| 31 Dec 20 | 14 | -2 | 8 | 0 |
| 30 Sep 20 | 15 | 1 | 8 | 0 |
| 30 Jun 20 | 19 | 3 | 9 | 0 |
| 31 Mar 20 | 22 | 4 | 10 | 0 |
| 31 Dec 19 | 25 | 6 | 11 | 0 |
| 31 Dec 18 | 15 | 4 | 6 | 0 |
Quality Earnings: SBBC is currently unprofitable.
Growing Profit Margin: SBBC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SBBC is unprofitable, and losses have increased over the past 5 years at a rate of 51.7% per year.
Accelerating Growth: Unable to compare SBBC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SBBC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-44%).
Return on Equity
High ROE: SBBC has a negative Return on Equity (-357.38%), as it is currently unprofitable.